ftInvstr
VALIANTLAB · Healthcare ₹111.51 -2.0% Mkt Cap ₹606 Cr

VALIANTLAB

Healthcare Drug Manufacturers - Specialty & Generic
₹111.51
-2.0% today · 30d -6.1%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for VALIANTLAB. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹117 Cr
+152.74% YoY
NET PROFIT
₹0 Cr
+106.6% YoY
OPM
4.52%
+2.51pp YoY
EPS
₹0.08
PE 38.89
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-7.4% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
VALIANTLAB38.891.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
63
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation FAIR 40
Growth STRONG 75
Profitability AVERAGE 30
Technicals NEUTRAL 53
Risk LOW 90
Key Stats
TTM PE
38.89
P/B
1.7
52W HIGH
₹141.38
OFF HIGH
-21.13%
DIV YIELD
0.0%
MKT CAP
₹606 Cr
◉ Active Signals
MACDBearish-2.4293
RSI(14)Bearish36.55
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VALIANTLAB and at what entry.

Sign up freeSign in